Search

Simulations Plus Inc

Chiusa

SettoreSettore sanitario

18.35

Panoramica

Variazione del prezzo dell'azione

24h

Corrente

Minimo

18.35

Massimo

18.39

Metriche Chiave

By Trading Economics

Entrata

-960K

3.6M

Vendite

-2.4M

22M

P/E

Media del settore

45.875

57.002

EPS

0.3

Margine di Profitto

16.335

Dipendenti

212

EBITDA

-6.3M

1.1M

Raccomandazioni

By TipRanks

Raccomandazioni

Neutrale

Previsioni per 12 mesi

-6.05% downside

Statistiche di mercato

By TradingEconomics

Capitalizzazione di Mercato

-48K

371M

Apertura precedente

18.35

Chiusura precedente

18.35

Notizie sul Sentiment di mercato

By Acuity

50%

50%

154 / 340 Classifica in Healthcare

Simulations Plus Inc Grafico

Le prestazioni passate non sono un indicatore affidabile dei risultati futuri.

Notizie correlate

17 ago 2026, 23:56 UTC

News
Social Media

Axon Enterprise shares are lower in after-market hours, following a report highlighting high valuations and recent military contracts from Bulgaria.

17 ago 2026, 23:56 UTC

News

Warner Bros Discovery shares are lower in after-market trading amid ongoing litigation over its merger with Paramount, which faces a $1.9 billion bond request.

17 ago 2026, 23:56 UTC

News

Allstate Corp shares are lower in after-market hours amid broader market weakness. Geopolitical concerns are affecting trading sentiment despite recent positive earnings highlights.

17 ago 2026, 23:56 UTC

News

Replimune Group Inc shares are lower in after-market hours amid negative sentiment from multiple class action lawsuits alleging securities fraud and misleading statements.

17 ago 2026, 23:46 UTC

Correlated Moves
News

ManpowerGroup Inc shares are lower in after-market hours amid concerns over declining sales and profitability, with operating margins reported at just 1.5%.

17 ago 2026, 23:46 UTC

News

Wix.com Ltd faces a securities class action lawsuit over alleged false statements about its AI offerings, contributing to shares trading roughly flat in after-hours activity.

17 ago 2026, 23:41 UTC

News

Coherus BioSciences announced a special dividend of contingent value rights, boosting shares in after-market trading following the company's strategic asset sale initiative.

17 ago 2026, 23:41 UTC

News
Social Media

XP Inc shares are lower in after-market hours after announcing a share cancellation and reporting mixed Q2 results, including adjusted net profit above estimates.

17 ago 2026, 23:36 UTC

News

Whirlpool Corp is identified as a sell by Yahoo Finance amid concerns over declining sales and profitability. Shares are trading lower in after-market hours.

17 ago 2026, 23:36 UTC

News

Enovix Corp shares are rising in after-market trading, rebounding from recent lows amid leadership changes and broader market declines for the Dow and S&P 500.

17 ago 2026, 23:31 UTC

News

Fred Stephan named President and CEO effective November 1, 2026.

17 ago 2026, 23:31 UTC

News

Zeta Global shares are lower in after-market hours, despite positive coverage highlighting strong performance and anticipated revenue growth of 25.1%.

17 ago 2026, 23:21 UTC

News

AT&T Inc. shares are higher in after-market trading following a successful €1.2 billion and $1.1 billion notes issuance to enhance liquidity and capital structure.

17 ago 2026, 23:16 UTC

News

Patterson-UTI Energy highlighted in Yahoo Finance cautionary analysis

17 ago 2026, 23:16 UTC

Social Media
News

Wendy's Co. shares are lower in after-market hours following the announcement of President Pete Suerken's resignation and a restructuring plan.

17 ago 2026, 23:16 UTC

News

Valero Energy shares are higher in after-market hours following analyst upgrades and price target increases amid rising crude oil prices linked to Middle East tensions.

17 ago 2026, 23:11 UTC

News

Nasdaq Inc plans to extend U.S. trading hours to nearly 23 hours daily starting December 6, 2026, pending regulatory approval. Shares are higher in after-market trading.

17 ago 2026, 23:06 UTC

News

DigitalOcean Holdings Inc. launched Managed AI Agents via Cloudways, contributing to shares trading higher after the market closed.

17 ago 2026, 23:01 UTC

News

Mitek Systems appoints Aaron Seyler as Chief Revenue Officer, effective August 17, 2026. Shares are trading higher in after-market hours.

17 ago 2026, 23:01 UTC

News

CACI awarded a contract worth up to $981 million with the U.S. Space Force, yet shares are trading lower in after-market hours.

17 ago 2026, 23:01 UTC

News

Targa Resources has secured long-term midstream agreements with ExxonMobil and plans to invest $5 billion in new projects, driving shares higher in after-market trading.

17 ago 2026, 23:01 UTC

News

Becton Dickinson appoints Gary Sorsher as executive vice president and chief quality officer, effective September 8. Shares are higher in after-market trading.

17 ago 2026, 23:01 UTC

News

Science Applications International Corp is under scrutiny after being flagged by Yahoo Finance. Shares are lower in after-hours trading following concerns over revenue projections.

17 ago 2026, 23:01 UTC

Correlated Moves
News
Social Media

iShares 20+ Year Treasury Bond ETF gains in after-market trading, reflecting market sentiment influenced by rising crude oil prices amid geopolitical tensions.

17 ago 2026, 23:01 UTC

News
Correlated Moves

BlackRock Inc shares declined in after-market trading, continuing a trend of lower daily closes amid geopolitical tensions and rising crude oil prices.

17 ago 2026, 22:56 UTC

Correlated Moves
News

Kulicke and Soffa Industries shares are lower in after-market trading following the announcement of Dr. Raj Talluri as the new CEO, effective September 2026.

17 ago 2026, 22:56 UTC

News

ComEd allocates over $170,000 to enhance public safety in 24 Illinois communities through its Powering Safe Communities Program. Exelon shares are higher in after-market trading.

17 ago 2026, 22:51 UTC

Social Media
News

Kura Oncology shares rose in after-market trading after CEO Troy Wilson's $1.11 million stock purchase and positive earnings report highlighting $9.1 million in revenue.

17 ago 2026, 20:07 UTC

News

Levi Strauss faces analyst skepticism over revenue performance and cash flow margins. The consensus price target is $28.27, implying a potential return of 26.2%.

17 ago 2026, 20:07 UTC

News
Correlated Moves

The iShares 7-10 Year Treasury Bond ETF is trading lower amid rising 10-year Treasury yields and geopolitical tensions affecting economic growth and inflation expectations.

Confronto tra pari

Modifica del prezzo

Simulations Plus Inc Previsione

Obiettivo di Prezzo

By TipRanks

-6.05% in calo

Previsioni per 12 mesi

Media 17.25 USD  -6.05%

Alto 18.5 USD

Basso 16 USD

Basato su 4 analisti di Wall Street che offrono Obiettivi di Prezzo a 12 mesi per Simulations Plus Inc - Dist negli ultimi 3 mesi.

Consenso sulla valutazione

By TipRanks

Neutrale

4 ratings

0

Acquista

4

Mantieni

0

Vendi

Sentiment

By Acuity

154 / 340 Classifica in Settore sanitario

Notizie sul Sentiment di mercato

Neutral

Volatilità

Sotto la media

Volume delle notizie (RCV)

Sotto la media

Notizie finanziarie

Spese di vendita e di amministrazione

Spese operative

Utile prima delle imposte

Vendite

Costo delle vendite

Utile lordo sulle vendite

Interessi passivi sul debito

EBITDA

Utile operativo

$

Chi Siamo Simulations Plus Inc

Simulations Plus, Inc. develops drug discovery and development software for modeling and simulation, and prediction of molecular properties utilizing artificial intelligence and machine learning based technology worldwide. The company operates through Software and Services segments. It also offers GastroPlus, which simulates the absorption and drug interaction of compounds administered to humans and animals; and DDDPlus and MembranePlus simulation products. In addition, the company provides products based on mechanistic and mathematical models, such as DILIsym, NAFLDsym, ILDsym, IPFsym, RENAsym, MITOsym, and OBESITYsym products. Further, it offers Absorption, Distribution, Metabolism, Excretion, and Toxicity Predictor for chemistry-based computer program that takes molecular structures as inputs and predicts their properties; and MedChem Designer, as well as MonolixSuite products for modeling and simulation that allows for population analyses, rapid clinical trial data analyses, and regulatory submissions. Additionally, the company provides clinical-pharmacology-based consulting services, which includes population pharmacokinetic and pharmacodynamic modeling, exposure-response analyses, clinical trial simulations, data programming, and technical writing services in support of regulatory submissions; and early drug discovery services. Furthermore, it offers creative and insightful consulting services to support its quantitative systems pharmacology and other modeling systems. The company serves pharmaceutical, biotechnology, agrochemical, cosmetics, and food industry companies, as well as academic and regulatory agencies. Simulations Plus, Inc. was incorporated in 1996 and is headquartered in Lancaster, California.
help-icon Live chat